Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
doi: 10.1038/srep12593 136 JiaoKZengGNiuLNYangHXRenGTXuXYet al
Most patients experience peak nausea and cramping for 37 days after dose escalation, with symptoms typically resolving within 1014 days as your body adapts
The upper body is not affected (except for arms in some types), so the size of the lower body is disproportionate and the body shape is distorted
User experimentation suggests that longer initial treatment periods (6+ months continuous) support better benefit retention during subsequent breaks, complete discontinuation breaks of 1-2 months show acceptable benefit maintenance for most users, and very extended breaks (3-6+ months) increase risk of regression toward pre-treatment baseline particularly for short initial treatment courses
US$ 23.37
US$ 22.35
US$ 25.37
US$ 23.28
US$ 22.43
US$ 23.32
